How Close are we to a Useable Genomic Risk Score for CAD?


Related at vwbg.org

Cardiovascular Aging: Can We Mitigate its Deleterious Effects?

Susan Cheng, MD, MPH, MMSc
Cedars Sinai - Smidt Heart Insitiute
Los Angeles, CA

HIV as a Model of Inflammation in Atherosclerosis

Priscilla Hsue, MD, FACC
University of California
San Francisco, CA

Aminopeptidase A Inhibition: A Novel Approach to Hypertension in High Risk Patients

Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA
Tulane University School of Medicine
New Orleans, LA
More related